Loading clinical trials...
Loading clinical trials...
Randomized Controlled Trial Investigating the Use of Next-generation Sequencing in Directing the Antimicrobial Treatment of Periprosthetic Joint Infection
Conditions
Interventions
Culture-based treatment
Next Generation Sequencing (NGS) with Culture
Locations
9
United States
University of Southern California
Los Angeles, California, United States
Cleveland Clinic Florida
Weston, Florida, United States
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States
Columbia University
New York, New York, United States
University of Rochester
Rochester, New York, United States
Northwell Health
Staten Island, New York, United States
Start Date
September 21, 2022
Primary Completion Date
May 1, 2024
Completion Date
May 1, 2025
Last Updated
November 8, 2023
NCT07406893
NCT05169229
NCT06062251
NCT06464770
NCT05159739
NCT06440564
Lead Sponsor
Center for Innovation and Research Organization
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions